Difference between revisions of "Tirabrutinib (Velexbru)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== BTK inhibitor ==Diseases for which it is used== *Waldenström macroglobulinemia ==History of changes in PMDA indication== *2020-08-21: new indica...") |
(No difference)
|
Revision as of 00:34, 7 June 2023
Mechanism of action
BTK inhibitor
Diseases for which it is used
History of changes in PMDA indication
- 2020-08-21: new indications for the treatment of Waldenström's macroglobulinemia and lymphoplasmacytic lymphoma.